Lonapegsomatropin

隆培生长激素

Report date: 2026/05/23 20:00:57

Base Information

Drug NameLonapegsomatropin
Drug Alias Name隆培促生长素TransCon PEG hGHTransCon PEG growth hormoneTransCon growth hormoneTransCon PEG somatropin +[10] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyIdiopathic short statureEndocrine System Diseases +[7] 
Global Approved IndicationsGrowth hormone deficiency
Approved Indications in ChinaGrowth hormone deficiency
Original Approved Country/TerritoryUnited States
Original Approved Date2021/08/25
Country/TerritoryCzechiaArmeniaBulgaria +[34] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAscendis Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAscendis Pharma Endocrinology Division AsAscendis Pharma A/STeijin Pharma Ltd
Inactive CompaniesVisen Pharmaceuticals (Shanghai) Co LtdRentschler Biopharma Se
Active IndicationsGrowth hormone deficiencyIdiopathic short statureEndocrine System Diseases +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG